Breaking down the cell wall: Strategies for antibiotic discovery targeting bacterial transpeptidases.

  title={Breaking down the cell wall: Strategies for antibiotic discovery targeting bacterial transpeptidases.},
  author={Stephen A. Cochrane and Christopher T. Lohans},
  journal={European journal of medicinal chemistry},

Figures from this paper

The Bacterial Cell Wall: From Lipid II Flipping to Polymerization.

Progress made toward understanding the translocation of Lipid II across the cytoplasmic membrane by the MurJ flippase is highlighted as well as the recent discovery of a novel class of PG polymerases, the SEDS (shape, elongation, division, and sporulation) glycosyltransferases RodA and FtsW.

Effects of Inactivation of d,d-Transpeptidases of Acinetobacter baumannii on Bacterial Growth and Susceptibility to β-Lactam Antibiotics

It is shown that PBP3 is essential for A. baumannii survival, as deletion mutants of this d,d-transpeptidase were not viable, and the simultaneous inhibition of PBP1a and PBP2 or PBPs in combination with LdtJ could represent potential strategies for the design of novel drugs against the bacterium.

The l,d-Transpeptidase LdtAb from Acinetobacter baumannii Is Poorly Inhibited by Carbapenems and Has a Unique Structural Architecture.

X-ray crystallographic studies revealed that LdtAb has a unique structural architecture and is the only known LDT to have two different peptidoglycan-binding domains, and mass spectrometry experiments showed that LDTAb forms complexes in vitro only with carbapenems.

New approaches and techniques for bacterial cell wall analysis.

Myxococcus xanthus as a Model Organism for Peptidoglycan Assembly and Bacterial Morphogenesis

It is argued that the Gram-negative bacterium Myxococcus xanthus is an ideal model for understanding PG assembly and bacterial morphogenesis, because it forms rods and spheres at different life stages.

First Penicillin-Binding Protein Occupancy Patterns for 15 β-Lactams and β-Lactamase Inhibitors in Mycobacterium abscessus

These first PBP occupancy patterns in M. abscessus provide a mechanistic foundation for selecting and optimizing safe and effective combination therapies with β-lactams.

Racemases and epimerases operating through a 1,1-proton transfer mechanism: reactivity, mechanism and inhibition

This review summarises the catalytic mechanisms of PLP-dependent, enolase family and cofactor-independent racemases and epimerases operating by a deprotonation/reprotonation (1,1-proton transfer) mechanism and methods for measuring their catalytic activity.

Identification and characterization of the novel bioactive compounds from microalgae and cyanobacteria for pharmaceutical and nutraceutical applications

Comprehensive knowledge about the exploration, extraction, screening, and trading of bioactive products from microalgae and cyanobacteria and their pharmaceutical and other applications will open up new avenues for drug discovery and bioprospecting.



Targeting the Bacterial Transglycosylase: Antibiotic Development from a Structural Perspective.

The structural studies of this protein are reviewed and recent progress in developing its specific inhibitors are summarized, including synthetic substrate analogs and novel compounds identified from high-throughput screens.

Lipid II as a target for antibiotics

Progress in understanding of the antibacterial activities of these compounds are reviewed, which include lantibiotics, mannopeptimycins and ramoplanin, and factors that will be important in exploiting their potential as new treatments for bacterial infections are considered.

Factors essential for L,D-transpeptidase-mediated peptidoglycan cross-linking and β-lactam resistance in Escherichia coli

Production of YcbB was sufficient to switch the role of (p)ppGpp from antibiotic tolerance to high-level β-lactam resistance and identify a new mode of peptidoglycan polymerization in E. coli that relies on an unexpectedly small number of enzyme activities.

Non-classical transpeptidases yield insight into new antibacterials

This work has characterized the molecular mechanisms responsible for inhibition of l,d-transpeptidases of M. tuberculosis and a range of bacteria, including ESKAPE pathogens, and utilized this information to design, synthesize and test simplified carbapenems with potent antibacterial activity.

Transpeptidase-mediated incorporation of D-amino acids into bacterial peptidoglycan.

It is demonstrated that this transpeptidase accepts a set of structurally diverse D-amino acid substrates and incorporates them into PG fragments, providing new information on donor and acceptor requirements as well as a mechanistic basis for previous observations that noncanonical D-Amino acids can be introduced into the bacterial cell wall.

Synthetic peptidoglycan substrates for penicillin-binding protein 5 of Gram-negative bacteria.

PBP5 of Escherichia coli would appear to have the potential for turnover of as many as 1.4 million peptidoglycan strands within a single doubling time (i.e., generation) of E. coli.

Lipid II overproduction allows direct assay of transpeptidase inhibition by β-lactams

A general approach to accumulate Lipid II in bacteria and to obtain large quantities of this cell wall precursor will enable a better understanding of cell wall biosynthesis and facilitate studies of next-generation transpeptidase inhibitors.

Does the cell wall of bacteria remain a viable source of targets for novel antibiotics?

Metabolic labelling of the carbohydrate core in bacterial peptidoglycan and its applications

The synthesis of modifiable NAM carbohydrate derivatives and the installation of these building blocks into the backbone of Gram-positive and Gram-negative bacterial PG utilizing metabolic cell wall recycling and biosynthetic machineries are reported.